The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Tadalafil once daily: Narrative review of a treatment option for female sexual dysfunctions (FSD) in midlife and older women
Abstract
Female Sexual Disorders (FSD) include a complex, multidimensional, individual experience that can change as an individual age, suggesting that these problems are caused by multiple factors including psychosocial factors, personal relationships, pathologic changes caused by diseases, and pharmacologic influences. Menopause is an important time for middle aged women and postmenopausal physiological changes could have a significant role in the development of FSD. Few is still known about their correct definition and treatment. Their incidence, prevalence and risk factors are difficult to define because of a high level of overlap in the experience of problems with desire, arousal, and orgasm. Little evidences are known about the best therapeutic approach, and both non-pharmacological and pharmacological treatment options have been described. Among these, phosphodiesterase type 5 inhibitors could be an effective option for many subtypes of female sexual disorders, with an improvement in different aspects of sexual function, such as desire, arousal, orgasm and sexual satisfaction. In this paper authors reviewed what is already known about the use of these vasoactive agents, particularly tadalafil, as a treatment option for female sexual disturbances.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This is consistent with previous studies that reported that the use of food slows down the effect of tadalafil [50].”
From Food Administration and Not Genetic Variants Causes Pharmacokinetic Variability of Tadalafil and Finasteride (2023) · cites this paper as [50]
In the citing paper
“Tadalafil is also used in women, since it is commonly prescribed for pulmonary hypertension management [49,50,51].”
From Food Administration and Not Genetic Variants Causes Pharmacokinetic Variability of Tadalafil and Finasteride (2023) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sexual Problems and Distress in United States Women: Prevalence and Correlates
Shifren, J. L., Monz, B. U., Russo, P. A., Segreti, A., & Johannes, C. B. (2008) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3181898cdb · Cited by 1,394
McCabe, M. P., Sharlip, I. D., Lewis, R., Atalla, E., Balon, R., Fisher, A. D., Laumann, E., Lee, S. W., & Segraves, R. T. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2015.12.034 · Cited by 577
Safarinejad, M. R. (2006) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901440 · Cited by 371
Hayes, R. D., Dennerstein, L., Bennett, C. M., & Fairley, C. K. (2008) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2007.00768.x · Cited by 301
Recent and Lifelong Sexual Dysfunction in a Female UK Population Sample: Prevalence and Risk Factors
Burri, A., & Spector, T. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02341.x · Cited by 162
Incidence of sexual dysfunction: a prospective survey in Ghanaian females
Amidu, N., Owiredu, W. K., Woode, E., Addai-Mensah, O., Quaye, L., Alhassan, A., & Tagoe, E. A. (2010) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-8-106 · Cited by 97
de Visser, R. O., Richters, J., Rissel, C., Badcock, P. B., Simpson, J. M., Smith, A. M. A., & Grulich, A. E. (2014) · Sexual Health · doi:10.1071/sh14112 · Cited by 38
Cited by
Villapalos-García, G., Zubiaur, P., Marián-Revilla, C., Soria-Chacartegui, P., Navares-Gómez, M., Mejía-Abril, G., Rodríguez-Lopez, A., González-Iglesias, E., Martín-Vílchez, S., Román, M., et al. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13111566 · Cited by 4
Metadata
- Authors
- Borghi, C., & Dell'Atti, L.
- Venue
- Archivio Italiano di Urologia e Andrologia
- Publisher
- PAGEPress Publications
- Published
- 2017-03-31
- Volume
- 89
- Issue
- 1
- Pages
- 7
- ISSN
- 2282-4197
- 1124-3562
- Cited by
- 4
- References
- 7
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
